Edwin J Wagena

Title: Edwin J Wagena: Innovator in Cell Therapy

Introduction

Edwin J Wagena is a notable inventor based in Brighton, GB. He has made significant contributions to the field of medical technology, particularly in the treatment of lower extremity peripheral artery disease. His innovative approach focuses on utilizing cell suspensions derived from adult bone marrow.

Latest Patents

Wagena holds a patent for a cell suspension intended for use in the treatment of lower extremity peripheral artery disease. The patent describes a cell suspension of autologous or allogeneic, preferably autologous, adult bone marrow-derived white blood cells. These cells are enriched for mononuclear cells, ensuring that more than 25% of the white blood cells present in the suspension are mononuclear cells.

Career Highlights

Throughout his career, Edwin J Wagena has worked with various organizations, including Rexgenero Biosciences S.L. and Servicio Andaluz De Salud. His work has focused on advancing medical treatments through innovative cell therapies.

Collaborations

Wagena has collaborated with notable professionals in his field, including Inmaculada Concepción Herrera Arroyo and Liesbeth De Jong. These collaborations have contributed to the development and refinement of his innovative approaches.

Conclusion

Edwin J Wagena's contributions to cell therapy represent a significant advancement in the treatment of peripheral artery disease. His innovative patent and collaborative efforts highlight his commitment to improving medical outcomes through research and development.